Latest news with #GlucoseMonitors
Yahoo
28-02-2025
- Health
- Yahoo
Four tech wearables designed to improve our health, from Apple AirPods to Oura rings
Wearable technologies are continuing to become part of everyday life, particularly the devices that aim to help us track and improve our health. New advancements are being made all the time, with devices like step counters and sleep trackers becoming more popular in recent years. Most recently, Apple introduced a new feature in the AirPods Pro 2 that allows them to be used as a hearing aid. The feature is now available in the UK and aims to help millions of people with hearing loss. We take a closer look at the new AirPods Pro 2 feature, as well as other health-related devices that have become all the rage. The technology that allows the AirPods Pro 2 to be used as hearing aids is now available in the UK as a free software update. According to the British Academy of Audiology, around 11 million people in the UK live with some degree of hearing loss, making it the second most common disability in the country. Research has shown that hearing loss can have an impact on a person's overall health and wellbeing if left untreated. Hearing loss is also linked to a higher risk of developing dementia, and can have a significant impact on a person's quality of life. Apple AirPods Pro 2 users can take a Hearing Test using the earbuds, which takes about five minutes, in order to create a personalised hearing profile. The hearing aid feature enables personalised adjustments so users can boost the sounds around them in real time. Commenting on the new feature, health and social care secretary Wes Streeting said: "It is estimated that half of people with hearing problems don't use hearing aids, so new products like this can help more people better manage their health. "As technology turbo-charges, we will work hand-in-hand with business to make sure as many Brits as possible reap the rewards." Armed with up to two times more noise cancellation than its predecessor and a six hour battery life, over 5,000 pairs of the fully automatic, noise-cancelling earphones have been sold in just the last month on Amazon. Continuous Glucose Monitors (CGMs) are small sensors that can be attached to a person's upper arm or tummy. It measures the amount of glucose is in the fluid under the skin, feeding the information to an app or a reader so the user can keep track of their blood glucose levels. The technology is commonly used by people with type 1 diabetes, who use the CGMs to see how their body responds to different foods. They also use it to determine how much insulin they might need at any given moment. However, the rise in popularity of platforms like ZOE has fueled an uptick in people without diabetes using CGMs to track their health and diet. Celebrities like Davina McCall swear by ZOE, which offers personalised diet plans based on data it collects from the CGMs it hands out to users. While CGMs are extremely useful for diabetics to avoid glucose spikes - which can lead to hyperglycaemia - they may not be providing accurate data for those who aren't diabetic. This is because a number of lifestyle factors can influence glucose readings, resulting in a report that can be difficult to interpret and that may lead people to cut out food unnecessarily. Exercise, hormones, and stress all play a role in blood glucose levels. Oura rings have exploded in popularity recently, as the tiny yet smart device has been promoted by celebrities and athletes for its tracking capabilities. Famous faces like Jennifer Aniston, Molly-Mae Hague, Gwyneth Paltrow, and even Prince Harry have been seen sporting the sleek band around their fingers. The device is less bulky than a smartwatch and blends in more seamlessly with the wearer's personal style, making it highly popular. Most prominently, it tracks the wearer's sleep, giving you a score out of 100 every morning according to how well you slept and how prepared your body is for the day ahead. It is particularly popular among individuals taking part in the viral "sleepmaxxing" trend on TikTok, in which people are using a number of techniques to improve their sleep quality and quantity. According to some reviews, the Oura ring can also help track menstrual cycles by monitoring temperature, and predict when you're getting ill before symptoms arrive. However, despite its sleek and minimal design, it can get in the way of some activities, like cycling and weightlifting. For these types of activities, a smart watch is likely more appealing. This revolutionary smart ring works alongside the world-class personal health Oura App to provide members with accurate and personalised daily health data, insights, and guidance. Smartwatches have been around for a number of years now, and the technology in them has seen huge advancements. In fact, some users have said their smartwatch "saved" them from a heart attack by alerting them when their heart rate became abnormally high. One woman in Canada said her Apple watch alerted her to an alarmingly high heart rate of 220, prompting her to call an ambulance. Other users have said the Apple Watch can help them catch disorders like sleep apnea, as well as detect when they're getting ill before they start feeling any symptoms. A number of smartwatches now have electrocardiogram (ECG) capabilities, which allows them to read the heart's electrical activity. This means the watch can detect an irregular heartbeat, which could be a sign of a stroke. Beyond heart health, researchers also believe smartwatches can identify Parkinson's disease years before a person is clinically diagnosed. A 2023 study by researchers at Cardiff University found that smartwatches can detect subtle abnormalities in their walking patterns, which made it possible to identify individuals with signs of Parkinson's disease up to seven years before their clinical diagnosis. Enjoy advanced fitness and health features with Apple's latest watch model, designed with a larger display, thinner and lighter frame and faster charging. Read more about health and wellness: I wore the Gwyneth-approved Oura ring for a month – did it fix my life? (The Independent, 9-min read) The tiny blood pressure sensor that could end up saving your life (Yahoo News, 4-min read) Six exercises to keep your heart healthy after sitting for too long (Yahoo Life UK, 4-min read)
Associated Press
19-02-2025
- Health
- Associated Press
Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform
Health2Sync's SugarGenie app is experiencing rapid growth and positive reception in South Korea. The platform is being utilized in both hospital settings and through government programs. Health2Sync has partnered with Sanofi for hospital rollouts and integrated its solution with South Korea's Primary Health Care Chronic Disease Management Program, reaching over 100 healthcare institutions by December 2024 for diabetes, hypertension, and obesity care. Healthcare professionals praise the app for improving patient care: SugarGenie enhances the ability to monitor patient data, provide personalized guidance, and effectively manage chronic conditions like diabetes. TAIPEI, TAIWAN - Media OutReach Newswire - 18 February 2025 - Health2Sync, a leading provider of digital therapeutics solutions for chronic diseases, announced today that it is experiencing significant growth and positive feedback from healthcare professionals in South Korea. Since launching its app, SugarGenie, in January 2024, the company has witnessed a surge in adoption among healthcare institutions. The company's solution offers data integration, visualization, and personal insights to improve patient care quality and streamline clinical workflows. Health2Sync's 'SugarGenie' app enables users to view their blood glucose and other lifestyle data in one place. While Health2Sync started rolling out its integrated diabetes management solution with Sanofi in hospitals and clinics in South Korea, the company also tapped into the local government's Primary Health Care Chronic Disease Management Program, which empowers doctors to engage with patients directly. As of December 2024, over 100 healthcare institutions have implemented Health2Sync's Patient Management Platform to enhance the care of patients with diabetes, hypertension, and obesity. 'Health2Sync's solution has been instrumental in improving the quality of treatment for our patients,' said Prof. SunJoon Moon, Gangbuk Samsung Hospital. 'We can easily monitor patients' data in the hospital and provide personalized guidance, significantly enhancing our ability to manage diabetes patients effectively.' The SugarGenie app captures data from various devices from renowned chronic disease management brands, including Abbott, Sanofi, Omron, Roche, and i-SENS. It allows automatic data synchronization from Continuous Glucose Monitors (CGMs), Blood Glucose Meters (BGMs), insulin caps such as SoloSmart™, and blood pressure monitors. Besides the vitals, other lifestyle data such as diet, medication, exercise, and sleep play crucial roles in chronic disease management. SugarGenie seamlessly connects with the iPhone's Health App and the Health Connect (such as Samsung Health) from Android phones. With patient consent, this comprehensive data is automatically transmitted to the platform, empowering healthcare providers with valuable insights for informed decision-making. To help patients better self-manage diabetes, the SugarGenie App offers automated engagement programs prescribed by doctors to deliver personalized education, reminders, and insights directly to patients. This innovative approach alleviates the burden on healthcare resources and enhances patient engagement. 'This platform is very useful for managing patients registered in the government's 'Primary Health Care Chronic Disease Management Program.' At our clinic, we monitor patients' self-measured data such as blood sugar and blood pressure and send educational materials and guides to patients' apps through the two-way messaging function,' said Dr. Kun-Ho Yoon, Dr. Yoon IM Clinic, former Chairman of the board, Korean Diabetes Association). Health2Sync has integrated with Eghis Healthcare, a leading Electronic Medical Record (EMR) company serving over 6,000 clinics in South Korea, to streamline clinical workflows. This synchronization enhances the efficiency and quality of chronic disease management by smoothly embedding Health2Sync's data with existing clinical systems. 'We are thrilled by the rapid adoption of Health2Sync's solutions in South Korea,' said Ed Deng, Co-founder and CEO of Health2Sync. 'Our commitment to improving patient outcomes through innovative digital therapeutics is unwavering, and we look forward to continuing to expand our reach and impact in this dynamic market."Hashtag: #health2sync #diabetesmanagement #digitaltherapeutis #digitalhealth The issuer is solely responsible for the content of this announcement. About Health2Sync Founded in 2013, Health2Sync offers digital solutions to help people with chronic diseases, pre-diabetes, or weight concerns to manage their health. The company's achievements include being the first approved digital therapeutics in Taiwan for their insulin dosage titration software, Insultrate, which they co-developed with Sanofi. The company has also received the 'NEXT BIG' Startup title from the Taiwan National Development Council.
Yahoo
12-02-2025
- Business
- Yahoo
Remote Patient Monitoring Market To Hit USD 88 Billion By 2030 : Wissen Research
The global remote patient monitoring (RPM) market is estimated to be valued at $40 Billion in 2023, and is expected to grow at a CAGR of ~12% during the forecast period (2024 – 2030) Remote patient monitoring market Sheridan, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The remote patient monitoring market is set to experience remarkable growth, fueled by a rising need for innovative healthcare solutions. As technology continues to advance and the focus shifts to patient-centered care, RPM provides a holistic way to manage chronic diseases and enhance patient outcomes. However, there are also challenges that stakeholders need to address to unlock the market's full potential. @ The RPM market is primarily driven by the rising burden of chronic diseases, which account for 71% of global deaths according to WHO. This is exemplified in diabetes care, where Continuous Glucose Monitors enable real-time blood sugar tracking and remote provider monitoring, leading to improved patient outcomes and reduced healthcare costs through fewer data management systems present a major market opportunity in Remote Patient Monitoring (RPM), with 76% of healthcare organizations reporting improved clinical decisions according to Healthcare Information and Management Systems Society (HIMSS). These systems aggregate data from multiple RPM devices to create comprehensive patient health profiles. The opportunity centers on developing platforms that provide AI-driven insights, automated alerts, and EHR integration. For example, Mayo Clinic's centralized RPM platform reduced cardiac patient readmissions by 40% through real-time data analysis, demonstrating how effective data management can improve outcomes while reducing fraud in Remote Patient Monitoring (RPM) presents a significant market challenge, particularly as the adoption of digital health solutions expands. Fraudulent activities include billing for non-existent patient monitoring sessions, falsifying patient data, and submitting claims for services not rendered. Common schemes involve providers billing for RPM services without proper patient consent, using automated systems to generate false readings, or charging for monitoring periods that exceed actual patient engagement times. Request Sample Report @ In 2023, RPM devices emerged as the dominant segment in the medical device market, primarily driven by the widespread adoption of vital sign monitors, blood glucose monitors, and cardiac monitoring devices. This dominance is attributed to the increasing prevalence of chronic diseases and the growing acceptance of wearable technology among patients. For instance, continuous glucose monitoring devices saw particularly strong growth, with market leader Dexcom reporting a 31% increase in global device shipments in diabetes segment led the Remote Patient Monitoring market in 2023, fueled by rising global diabetes cases (537 million adults in 2021 per IDF) and the need for continuous monitoring. This leadership position was strengthened by widespread adoption of advanced CGM systems and connected insulin pumps enabling real-time data sharing with healthcare patient monitoring serves a number of end-users such as hospitals, home care, ambulatory care centers and others. The traditional healthcare facilities, i.e. hospitals remained the significant holder of user market share due to increase in the adoption rates of RPM devices patient monitoring market research included a comprehensive analysis of five key regions: North America Europe Asia Pacific Middle East and Africa Latin America. Regions were assessed on healthcare infrastructure, regulations, tech adoption, and market dynamics. North America dominated the remote patient monitoring market due to advanced healthcare systems, high adoption rates, and the presence of major industry innovators. As per the historical and the base year of the report (2022 and 2023, respectively), key players in remote patient monitoring were Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers Ag (Germany), Omron Healthcare (Japan), Boston Scientific Corporation (US), Abbott Laboratories (US), Resideo Life Care Solutions (US), among for Customization @ Latest Reports from Wissen Research Dental Implants & Prosthetics Market Point-of-care Diagnostics Market Lyme Disease Treatment Market In Vitro Diagnostics Market About us: Wissen Research is a leading market research firm that serves over 800 clients, with 40% of the top 2,000 companies relying on us for insights into key business questions and the identification of new high-growth and niche revenue opportunities. In a world marked by constant technological innovation and market disruptions, we assist organizations in planning and operationalizing their future revenue strategies by uncovering numerous growth opportunities. Companies choose Wissen Research to stay ahead of the competition and make informed revenue decisions, leveraging actionable insights and recommendations that give them a unique first-mover advantage. Our research methodology delivers quantifiable and actionable insights into interconnected market ecosystems shaped by disruptive technologies and emerging markets. We not only focus on factors that will impact our clients' revenue but also explore what could affect their customers' revenue by revealing latent and adjacent market opportunities. We collaborate across all B2B sectors, engaging with C-level executives in areas such as R&D, intellectual property, strategy, marketing, sales, product development, and M&A. Wissen Research offers exclusive market intelligence from over 120 subject matter experts and analysts, complemented by our high-growth niche market studies and consulting services. Attachment Remote patient monitoring market CONTACT: Mayur Jain Wissen Research LLC Gould St, Ste R Sheridan, WY 82801 Phone: (+91) 7814300364 info@ in to access your portfolio
